Hackett HK, Boulet LM, Dominelli PB, Foster GE. A methodological approach for quantifying and characterizing the stability of agitated saline contrast: implications for quantifying intrapulmonary shunt. J Appl Physiol 121: 568 -576, 2016. First published June 30, 2016 doi:10.1152/japplphysiol.00422.2016.-Agitated saline contrast echocardiography is often used to determine blood flow through intrapulmonary arteriovenous anastomoses (Q IPAVA). We applied indicator dilution theory to time-acoustic intensity curves obtained from a bolus injection of hand-agitated saline contrast to acquire a quantitative index of contrast mass. Using this methodology and an in vitro model of the pulmonary circulation, the purpose of this study was to determine the effect of transit time and gas composition [air vs. sulphur hexafluoride (SF 6)] on contrast conservation between two detection sites separated by a convoluted network of vessels. We hypothesized that the contrast lost between the detection sites would increase with transit times and be reduced by using contrast bubbles composed of SF 6. Changing the flow and/or reducing the volume of the circulatory network manipulated transit time. Contrast conservation was measured as the ratio of outflow and inflow contrast masses. For air, 53.2 Ϯ 3.4% (SE) of contrast was conserved at a transit time of 9.25 Ϯ 0.02 s but dropped to 16.0 Ϯ 1.0% at a transit time of 10.17 Ϯ 0.06 s. Compared with air, SF 6 contrast conservation was significantly greater (P Ͻ 0.05) with 114.3 Ϯ 2.9% and 73.7 Ϯ 3.3% of contrast conserved at a transit time of 10.39 Ϯ 0.02 s and 13.46 Ϯ 0.04 s, respectively. In summary, time-acoustic intensity curves can quantify agitated saline contrast, but loss of contrast due to bubble dissolution makes measuring Q IPAVA across varying transit time difficult. Agitated saline composed of SF6 is stabilized and may be a suitable alternative for Q IPAVA measurement. (33, 42, 45, 46) . Such intrapulmonary arteriovenous anastomoses (IPAVAs) are large (25-500 m in diameter) shunt vessels (33, 45, 46) that are believed to impact pulmonary gas exchange efficiency (2, 12, 43, 44) . Over the past decade, studies have attempted to determine the mechanism(s) responsible for recruiting IPAVAs with the idea that they could be passively regulated by pulmonary distention (26), under humoral (9, 28, 47) or neural control (3). Though there is yet to be an agreement on which theory is most accurate, the magnitude of blood flow through IPAVAs (Q IPAVA ) appears to be modulated by stressors including exercise (43), hypoxia (28, 47), and hyperoxia (32). A detailed overview of recent research into the mechanisms regulating Q IPAVA can be found in several thorough reviews (10, 29).
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NEW & NOTEWORTHY
Indicator dilution theory can quantify agitated saline contrast and be used to characterize the stability of agitated saline contrast. Agitated saline contrast is unstable suggesting that any measure of blood flow through intrapulmonary arteriovenous anastomoses (Q IPAVA) should consider transpulmonary transit time. Gases with high density and low blood solubility sufficiently stabilize saline contrast. Because of contrast instability, Q IPAVA is likely underestimated at rest.
THERE IS ANATOMICAL EVIDENCE for the existence of direct vascular anastomoses between pulmonary arteries and veins in many mammals, including baboons, dogs, and healthy humans (33, 42, 45, 46) . Such intrapulmonary arteriovenous anastomoses (IPAVAs) are large (25-500 m in diameter) shunt vessels (33, 45, 46) that are believed to impact pulmonary gas exchange efficiency (2, 12, 43, 44) . Over the past decade, studies have attempted to determine the mechanism(s) responsible for recruiting IPAVAs with the idea that they could be passively regulated by pulmonary distention (26) , under humoral (9, 28, 47) or neural control (3) . Though there is yet to be an agreement on which theory is most accurate, the magnitude of blood flow through IPAVAs (Q IPAVA ) appears to be modulated by stressors including exercise (43) , hypoxia (28, 47) , and hyperoxia (32) . A detailed overview of recent research into the mechanisms regulating Q IPAVA can be found in several thorough reviews (10, 29) .
Blood flow through IPAVA is commonly detected using agitated saline contrast echocardiography, which involves the injection of a hand-agitated mixture of air and saline into a peripheral vein (30) . A bolus of agitated saline contrast is estimated to contain bubbles of normally distributed sizes with mean diameters ranging from 16 to 38 m (15, 16, 48) . Though bubbles small enough to traverse the pulmonary capillary bed exist, it is predicted that they should dissolve within 500 ms after agitation (14) . Agitated saline is injected into a peripheral vein, and bubbles are first detected in the right heart by echocardiography. Subsequently, the bubbles traverse the pulmonary circulation where they will either be filtered by the pulmonary capillaries or pass through an IPAVA and appear in the left heart (8, 36, 43) . This technique is predicated on absence of any form of intracardiac shunt or pulmonary arteriovenous malformation, both of which provide alternate pathways for contrast to reach the left ventricle. Unlike other commonly used contrast agents, saline contrast permits multiple injections within a small period of time but lacks an objective and quantifiable assessment of Q IPAVA and involves a contrast agent that may be susceptible to changes in transit time, blood gases, barometric pressure, and blood viscosity (14) . Applying indicator dilution theory to the backscattered acoustic signal produced when agitated saline contrast transits the chambers of the heart may provide a tool not only to characterize the properties of agitated saline contrast in vitro but also to ultimately generate a quantifiable approach to measure Q IPAVA using saline contrast echocardiography (4, 20, 21) .
On the basis of Henry's law, soluble gases held at a constant temperature in contact with a solvent will dissolve proportionally to the partial pressure of the given gas and its inherent solubility in the fluid. However, it is not known how this relationship impacts the use of agitated saline contrast for measuring Q IPAVA . Efforts to characterize the in vivo lifetime of these contrast bubbles have resulted in formulating a rela-tionship between the physical properties of the bubble and its time to complete dissolution assuming constant temperature and pressure (Eq. 1) (14, 39) .
In this equation, T is the dissolution time in seconds, R o is the initial bubble radius in micrometers, is the gas density in kg/m 2 , D is the diffusivity, and C s is the solubility of the gas (14) . Considering that bubbles have a limited lifetime, it would follow that the time period between contrast injection and visualization in the right and left ventricles is an important factor to consider when measuring Q IPAVA . This time period is not considered in previous reports and is not a component of existing shunt scoring methods. One could postulate that decreased pulmonary transit time, such as during exercise or acute hypoxia, would result in a greater percentage of the injected bubbles arriving at the left ventricle thereby increasing the estimate of Q IPAVA . Hence, when pulmonary transit times are longer, the use of more stable contrast agents would be needed to accurately estimate the shunt size at rest. According to Eq. 1, using a gas of increased density and reduced solubility would stabilize contrast bubbles and might minimize the transit time effect. Subjecting the agitated saline contrast technique to rigorous characterization in an in vitro model could help elucidate some of the questions surrounding this technique.
On the basis of this rationale, the purpose of this study was to apply concepts of indicator dilution theory and agitated saline contrast echocardiography to an in vitro model of the pulmonary vasculature with a saline perfusate to assess the influence of transit time, gas solubility, and gas density on the conservation of contrast. We hypothesized that the contrast lost between two detection sites would be reduced with decreasing transit times. In addition, we hypothesized that the amount of contrast lost between two detection sites would be minimized when bubbles are composed of sulphur hexafluoride (SF 6 ), an inert high-density gas with low solubility in blood compared with air. Since the volume of bubbles injected can lead to attenuation of the ultrasound beam and result in an underestimation of the acoustic intensity (21, 37), we determined the relationship between our "measured" contrast mass and the injected contrast volume for both air and SF 6 to identify the optimal injection volume.
MATERIALS AND METHODS

Experimental Setup
The in vitro setup used is a simplified model of the pulmonary vasculature as illustrated in Fig. 1 . A 10-liter basin was filled with 0.9% saline and served as a fluid reservoir to a centrifugal perfusion pump (540; BioMedicus, Eden Praire, MN) and in-line flow sensor (TX40; BioMedicus). The perfusion pump and flow probe were connected to a single 9.53-mm (ID) latex surgical tubing and were used to control the flow in the circuit. A fluid-filled manometer (MLT0670; ADInstruments, Colorado Springs, CO) was inserted into the latex surgical tubing distal to the flow sensor and assessed pressure in the circuit. The pressure signal was amplified (FE117; ADInstruments) and recorded continuously at 100 Hz using a commercially available data acquisition system (PowerLab 16/35; ADInstruments). The flow probe and pressure sensor were zeroed and calibrated at Fig. 1 . Schematic of the experimental setup. The saline reservoir feeds a perfusion pump enabling flows to be measured and controlled. Two ports into the inflow site serve as a port for a pressure catheter to continuously measure fluid pressure and an injection port for agitated saline contrast mixtures. The inflow tract then enters the imaging chamber where a cardiac ultrasound probe is located above to acquire two-dimensional cross-sectional cine loops of the contrast flowing through. Downstream from the inflow site is a network of surgical tubing resembling the pulmonary circulation in volume (variable between ϳ250 and 680 ml). The dotted lines (labeled by arrows) show the sites where one, two, or three branches of the capillary network can be clamped to manipulate the transit time for a given circulatory flow. The tubing collects into a single outflow tract before traveling through the imaging chamber to assess the amount of contrast reaching this detection point. Inset shows representation of the ultrasound image showing the inflow and outflow vessels in cross section. In this example, a region of interest encompasses the lumen of the inflow and outflow sites, and the resultant raw acoustic intensity vs. time curves are provided in yellow and blue. relevant rates/pressures before experiments and checked for accuracy immediately following experiments. Downstream of the pressure sensor, a 22-gauge hypodermic needle was inserted and fixed into the tubing lumen and served as a contrast injection site. Two three-way stopcocks were assembled each with 10-ml (or 5-ml) syringes to the injection site and were used to hand-agitate gas-saline mixtures. Beyond the injection site, the surgical tubing divided for three generations before converging back into a single tube returning to the 10-liter reservoir. A wye-shaped connector was used at all sites to split a generation. The tubing diameter was reduced in size from 9.53 to 6.35 mm (ID) when the network reached its largest cross-sectional area. The multiple-generation design permitted clamping of one, two, or three arms at the second generation of the circuit to manipulate the volume and the mean transit time for a given flow (see Fig. 1 ). The full tubing network had a volume similar to a typical human pulmonary blood volume (ϳ680 ml). To minimize the impact of hydrostatic forces, the system from the pump output was located at the same height, and the pressure sensor was referenced to this site. Finally, the principal inflow and outflow tubes passed through a small basin of water with an ultrasound probe (M5S; GE Healthcare, Piscataway, NJ) that was submerged and clamped above to acquire their twodimensional cross-sectional images (Vivid E9; GE Healthcare). By recording the backscattered acoustic intensity at the inflow and outflow tubes we were able to determine transit time, contrast mass, area under the time-acoustic intensity curve (AUC), and the amount of contrast conserved.
Ultrasound System and Configuration
Cross-sectional B-mode images of the inflow and outflow tubes were simultaneously acquired. The ultrasound acquisition settings were adjusted to optimize the image and remained constant for all experimental trials. Acquisition settings were as follows: harmonic imaging frequency, 3.5 MHz; mechanical index, 0.7 MHz; sampling frequency, 2.3 MHz; frames per second, 54.8; depth, 14 cm; dynamic range (compression), 57 dB; power, 0. For all trials, ultrasound images were acquired in raw format beginning at the time of injection and continuing until all the ultrasound contrast had cleared both the inflow and outflow sites of detection.
Experimental Protocol
Study 1. To determine the optimal injection volume, a series of trials (5 injections each) were conducted to identify the relationship between the injected contrast volume and the observed acoustic intensity response. To achieve this, 10, 8, 6, 4, and 2 ml of handagitated contrast with a 10:1 mixture of saline and gas (room air or SF 6) was injected into the circulatory network. Smaller volumes (Ͻ6 ml) were mixed in 5-ml syringes to improve the precision of volume measurements. The syringes of gas and saline were rapidly flushed back and forth for 10 s prior to its immediate injection into the system. During this time the flow of the system was maintained at 2.0 l/min. Study 2. To determine the effect of transit time on the conservation of contrast between detection sites, a series of studies (5 injections each) were performed where transit time was manipulated. In the first instance, flow in the system was set at 1.5 l/min, and zero, one, two, or three arms of the tubing network were clamped to manipulate transit time (see Fig. 1 ). The trials were then repeated using a flow of 2.0 l/min. A 10:1 mixture of saline and gas was utilized with a total injection volume of 6 ml. The series of studies were first conducted using room air and then repeated with SF6 to identify the impact of gas density (air, 1.225 kg/m 3 ; SF6, 6.17 kg/m 3 ) and solubility (air, 0.77 mol/m 3 ; SF6, 0.24 mol/m 3 at 25°C) on the conservation of contrast mass.
For all studies, room temperature was maintained at 23°C. In addition, to account for interindividual variability, the same investigator completed all injections and analyzed the data.
Data Analysis
Two-dimensional ultrasound cine loops were imported into commercially available image analysis software (EchoPac BT13; GE Healthcare). A quantitative analysis tool (Q-analysis) was used to draw circular regions of interest (diameter 9.5 mm) around the lumen of the inflow and outflow tube in the B-mode image, which then returned a mean acoustic intensity value for each region. The signals were plotted against time (time-acoustic intensity curves) and exported as text files. The text files were loaded into custom software (SoNo Shunt) written in LabView (version 13.0; National Instruments, Austin, TX). The time-acoustic intensity curves were first normalized to baseline and then fast Fourier transformed to identify the frequency of the contrast signal. A low-pass filter of 0.5 Hz was applied to the signal to remove high-frequency noise. The AUC values of the resultant time-acoustic intensity curves were calculated, and the ratio of the AUC values for the inflow and outflow tubes was used as one index of contrast conservation. To further quantify the contrast properties, an indicator dilution model known as the local density random walk (LDRW) model was fitted to the time-acoustic intensity curves (4). The LDRW model (see Eq. 2) describes a bolus injected into a flowing pipe and sampled at a given distance from the injection site.
where m is the mass of the indicator contrast, Q is the flow of the fluid in l/min, is a parameter describing the curves' skewness, is the mean transit time, and t is time. The time integral is represented in the LDRW equation by m/Q , and it directly corresponds to the quotient of the indicator mass (m) to the rate of blood flow or cardiac output (Q ). Time-acoustic intensity curves were fitted using an iterative least squares process with the following initial parameters. The contrast mass was initially set to 0.5 and 0.01 for inflow and outflow measurement sites, respectively. Q was set as the circuit flow (i.e., 1.5 or 2.0 l/min), and was set to 8.5 and 12.0 for inflow and outflow sites. The initial parameter for was estimated from the peak time. The mean square error provides a measure of goodness of fit. The ratio of the mass of the outflow tract to the mass of the inflow tract provides a second measure for the conservancy of contrast between the two detection sites. The transit time between detection sites was calculated as the difference in mean transit times from the inflow and outflow LDRW model parameters. Figure 2 provides a representative example of the filtered and modeled time-acoustic intensity curves for the inflow and outflow measurement sites.
Statistical Analysis
Data were compared and analyzed using statistical software (Statistica v7.0; Statsoft, Tulsa, OK). Measurements were compared statistically between all three conditions [gas type, flows, and circuit volume (i.e., clamping)] using a three-factor analysis of variance (ANOVA). When significant F-ratios were identified, Tukey's post hoc testing was conducted to dictate where the differences lay. Student's t-tests were conducted to identify differences between measured variables at the inflow and outflow sites. All data are presented as means Ϯ SE, and significance was set to P Ͻ 0.05.
RESULTS
Study 1
Figure 3 displays the contrast mass for the indicator dilution curves measured at the inflow site for both air and SF 6 at five different bolus sizes of agitated saline contrast. Throughout these experiments, flow was maintained at 2.0 l/min. The contrast mass measured by SF 6 was significantly greater than Ultrasound Contrast Dissolution • Hackett HK et al.
air at bolus sizes Ͼ4 ml (P Ͻ 0.05). For air, contrast mass tended to increase with bolus size, reaching a plateau at ϳ6 ml. Conversely, SF 6 increased significantly in contrast mass reaching a bolus size of 8 ml before plateauing (P Ͻ 0.05). SF 6 contrast masses at a bolus size of 8 and 10 ml were not different from one another. Area under the time-acoustic intensity curve followed a similar pattern (data not shown). On the basis of these data, a 6-ml bolus size was selected for both gases for study 2 as it provides the optimal working range capable of encoding the dose-dependent change in contrast mass due to dissolution of the contrast. Table 1 provides the measured flow, pressure, calculated transit time, and percent of contrast mass conserved between the inflow and outflow measurement sites. The desired flow was attained and did not significantly differ within the 1.5 and 2.0 l/min conditions. Similarly, flows and pressures were comparable between air and SF 6 trials. Transit times between detection sites ranged across experimental conditions from 9.12 Ϯ 0.03 s to 24.47 Ϯ 0.03 s, with the fastest (9.07 s) and slowest (24.52 s) occurring with 75% clamping and no clamping at 2 l/min, respectively. Compared with SF 6 , the transit time in the unclamped conditions (both 1.5 and 2.0 l/min) was significantly less (P Ͻ 0.05). In these conditions, the conservation of contrast mass was poor (Ͻ1%), and the ability to model the time-acoustic intensity curve was hindered. In the unclamped, 1.5 l/min flow, air conditions, two of the five trials were excluded because they could not be adequately modeled by the LDRW at the outflow site. With the exception of the above, transit times were similar for both air and SF 6 within respective clamping and flow conditions. Table 2 provides the AUC and select LDRW model parameters for both the inflow and outflow sites for both gases. The AUC and the contrast mass measured at the inflow site were variable in the air, 1.5 l/min flow condition [standard deviation (SD); AUC ϭ 0.16, contrast mass ϭ 0.25]. This variability was much less in all the SF 6 conditions (SD; AUC ϭ 0.02, contrast mass ϭ 0.07) and the air, 2.0 l/min flow condition (SD; AUC ϭ 0.01, contrast mass ϭ 0.03). For air and SF 6 , AUC and contrast mass were maximal for 75% clamped conditions when transit time was shortest. In all cases for air, the AUC and contrast mass at the outflow site were significantly less compared with the inflow tract (P Ͻ 0.05). For SF 6 , the AUC did not differ between the inflow and outflow sites in the 75% clamped at 1.5 l/min and in the 50% clamped in the 2.0 l/min condition. Lambda, representing the skewness factor of the LDRW model, was significantly greater at the outflow site compared with the inflow site (P Ͻ 0.05). There were no differences in lambda between conditions at the Fig. 3 . Dose-response curve to determine optimal contrast injection volume for air and SF6. Agitated saline contrast composed of either air or SF6 was mixed in a ratio of 10 parts saline to 1 part gas. The contrast solution was injected in varying doses (2, 4, 6, 8, and 10 ml), and the indicator dilution curve was modeled to determine the contrast mass. The contrast mass was then plotted against the dose volume to identify the linear portion of the dose-response curve. The highest dose volume on the linear dose-response curve (i.e., 6 ml) was selected as the optimal injection volume. This ensures any lesser dose due to contrast dissolution will be measureable on a linear trajectory. *P Ͻ 0.05 compared with 10-ml dose. †P Ͻ 0.05 compared with air for the same injection volume.
Study 2
inflow site. Finally, the mean square error, representing the goodness of fit of the LDRW, ranged from 2.4 Ϯ 1.3 ϫ 10 Ϫ5 to 1.4 Ϯ 0.4 ϫ 10 Ϫ11 . Figure 4 and Table 1 provide the percent of contrast conserved between inflow and outflow sites for contrast composed of air and SF 6 . For air, only 49.9 Ϯ 2.9% of contrast survived at a transit time of 9.25 Ϯ 0.02 s. This quickly dissipated such that only 4.5 Ϯ 0.1% of contrast survived to a transit time of 15.09 Ϯ 0.03 s. The loss of SF 6 to dissolution was greatly attenuated compared with air. For example, contrast bubbles composed of SF 6 were 100% conserved between transit times of 9 and 10 s. More than half (53.4 Ϯ 4.4%) of SF 6 contrast survived to 16.27 Ϯ 0.09 s. At all but the slowest transit times, the conservation of SF 6 was significantly greater than contrast composed of air (P Ͻ 0.05).
DISCUSSION
The main findings of this study are threefold. First, agitated saline contrast can be quantified as the area under the timeacoustic intensity curve, and as the mass parameter of an indicator dilution model such as the LDRW model. Second, the conservation of agitated saline contrast composed of air is time dependent with more than 50% of the contrast lost to dissolution in the span of a normal resting pulmonary transit time. Finally, agitated saline mixed with pure SF 6 is stabilized with Values are means Ϯ SE. *P Ͻ 0.05 compared with 75% clamped within each condition; †P Ͻ 0.05 compared with SF6; ‡P Ͻ 0.05 compared with 1.5 l/min condition. Contrast mass conserved is calculated as the ratio of inflow to outflow contrast mass based on the local density random walk model. Values are means Ϯ SE. Area under the curve and contrast mass presented as ϫ 10 Ϫ2 for clarity. a Significant interaction effect between gas and flow at the inflow site indicating that lambda was significantly less with SF6 and greater at 1.5 l/min for air but not SF6.
b P Ͻ 0.05 compared with 75% clamped within each condition;
c P Ͻ 0.05 compared with inflow; d P Ͻ 0.05 compared with SF6; e P Ͻ 0.05 compared with 1.5 l/min condition.
100% of contrast conserved within a normal resting pulmonary transit time. Our results illustrate the utility of time-acoustic intensity curves for quantifying agitated saline contrast objectively, and we provide a novel methodology capable of characterizing the stability of saline contrast. In addition, the time dependence of agitated saline contrast might explain the lack of Q IPAVA in humans at rest and the increased Q IPAVA when transit time is decreased during exercise and acute hypoxia.
Time-Acoustic Intensity Curve Analysis for Quantifying Q IPAVA
There is currently no available method to objectively quantify the magnitude of Q IPAVA using the technique of agitated saline contrast. In early studies, conservative methods were employed, and only the presence or absence of Q IPAVA was determined (11, 25, 32, 43) . Following these initial studies, interest shifted to identifying the mechanisms responsible for the recruitment of IPAVA (6, 9, 12, 27, 28, 34, 44, 47) . However, determining specific mechanisms required methodology to determine the magnitude of contrast appearing in the left ventricle. Scoring systems were adopted and adapted from semiquantitative scales often used in clinical practice for scoring the magnitude of right-to-left shunts with saline bubbles (1, 28, 32) . Although these methods take into account the density and spatial distribution of saline bubbles, they have not been validated either in vitro or in vivo and do not consider the time dependence of contrast dissolution (see below).
The application of indicator dilution theory to echocardiography was first employed by Hagler et al. (20) in 1982 to measure the magnitude of a left-to-right intracardiac shunt. However, the technique proved to be unreliable because of loss of data during video compression and the limited gray scale range associated with the cathode ray monitor technology (35) . Recent advancements in ultrasound technology now permit acoustic intensity measurements directly from manipulated ultrasound data without the need for video compression (40) . In addition, contrast technology has also advanced, making it now possible to use agents that are small enough to clear the lung to estimate ejection fraction, cardiac output, and pulmonary blood volume using the concepts of indicator dilution theory (21, 22, 37) . In our study, we employed similar methodology, using time-acoustic intensity curves to quantify the amount of contrast passing through two separate detection sites (see Fig. 2 ) with varying transit times.
To quantify the contrast mass using the time-acoustic intensity curve, the AUC can be used or the local density random walk model can be fit to the data and the mass parameter determined. In either case, the volume (or dose) of the injected contrast must be small enough to prevent attenuation (acoustic shadowing) of the measured acoustic intensity (21) . If the injected contrast dose is too great, the signal can become saturated, and the measured contrast mass can be underestimated. We quantified the dose-contrast mass relationship for contrast composed of air and SF 6 (see Fig. 3 ) and found that an injected volume of 6 ml was optimal for both gases permitting the quantification of contrast dissolution with a linear relationship between contrast mass and the injected dose. Interestingly, the contrast mass measured using contrast mixed with pure SF 6 is much greater, and the slope of the dose-contrast mass relationship is much steeper suggesting improved sensitivity. Similar results have been observed using encapsulated microbubbles filled with air or SF 6 (17) .
Across all experimental conditions we were able to quantify the contrast mass at the inflow site and the outflow site using the LDRW model or by measuring the area under the timeacoustic intensity curve. Modeling of the time-acoustic intensity curves was poor in the air condition when transit time was long because of very little contrast surviving to the outflow measurement site. As a result, the estimation of the transit time using the model parameters was less accurate, and this explains the large variability in transit time in some of the air trials compared with the SF 6 trials (see Table 1 and Fig. 4) . With the exception of the 1.5 l/min condition with contrast composed of air, the contrast mass measured at the inflow site was similar among trials of similar flow, suggesting a similar amount of contrast was injected across trials. However, since the measurement of contrast conservation and ultimately the measure of Q IPAVA represent the ratio of contrast mass measured at the outflow (i.e., left ventricle) and the inflow sites (i.e., right ventricle), the reproducibility of the injected contrast mass is not a necessity. The utility of this approach for quantifying Q IPAVA in humans is promising, but obtaining a continuous time-acoustic intensity curve from the right and left ventricles may be difficult given the characteristic intermittent blood flow within the cardiac chambers and the intermittent lung artifacts often present during eupnea and the hyperpnea associated with exercise and hypoxia. To deal with the intermittent blood flow within the cardiac chambers, it may be best to construct time-acoustic intensity curves from regions of interest positioned across the span of the atrioventricular valves thereby capturing contrast bubbles as they enter into the ventricles during diastole.
Time Dependence of Contrast Dissolution Should Be Considered When Measuring Q IPAVA
Agitated saline contrast is a highly unstable contrast agent (14, 48 dependence of bubbles in solution (14, 39) . If the time between injection and detection of agitated contrast in the left ventricle is reduced, it can be inferred that a greater proportion of the injected contrast travelling through an IPAVA could survive to the left ventricle. We found in a saline perfusate that the amount of contrast lost between detection sites with increasing transit time is considerable (see Table 1 and Fig. 4 ). For example, after 9 s has passed, nearly 50% of the contrast has been lost between detection sites for contrast mixed with air. We cautiously interpret our results to suggest that the time dependence of agitated saline contrast may contribute to the apparent recruitment of IPAVA during exercise and with acute hypoxia. According to Elliott et al. (13) only 30% of people free from intracardiac shunts have Q IPAVA in the resting state though the amount of contrast passing the lung was very small. This prevalence increases to nearly 95% of people during stresses such as exercise (11, 25, 32, 43) and acute hypoxia (9, 28, 47) . Could the low prevalence at rest and the reported increase in Q IPAVA with exercise and acute hypoxia be an effect of the time-dependent stability of saline contrast? We suggest that the true Q IPAVA at rest is underestimated while the Q IPAVA when transit times are reduced begins to approach the actual Q IPAVA as contrast stability and survivability are improved. During these stresses, transit time is significantly reduced from a typical resting transit time of 9 s to that expected during exercise of ϳ2-3 s. If we assume that the contrast decay curve was reasonably linear across this time interval, we could predict that 33-39% more contrast would survive with the transit times associated with exercise. In fact, the association between bubble score and cardiac output in healthy humans (12, 27) and in patients with acute respiratory distress syndrome (5) is good evidence for a relationship between the amount of contrast conserved and transpulmonary transit time. Finally, we previously studied sea level subjects during 20 min of acute normobaric hypoxia and again after 3 wk of acclimatization to 5,050 m (18) . Despite a similar hypoxic stimulus, seven of seven subjects demonstrated Q IPAVA during acute hypoxia while only one of eight subjects had Q IPAVA at high altitude. Interestingly, resting cardiac output at high altitude was similar to that during rest at sea level and suggests that the detection of left heart contrast depends on the transpulmonary transit time although it is possible that saline contrast is less stable at high altitude. We suggest that future studies work toward incorporating a quantitative measure of Q IPAVA by using time-acoustic intensity curve analysis and a measure of transpulmonary transit time to directly address the relationship between transit time and Q IPAVA . Several studies have been conducted in animals using microspheres or in humans using technetium-labeled macroaggregates ( 99m Tc-MAA). Unfortunately, these data are unequivocal for the interpretation of a transit time effect with saline contrast. For example, Bates et al. (2) found that the transpulmonary transit of 99m Tc-MAA was greatest resting in hypoxia compared with both normoxic and hypoxic exercise. This is opposite to that observed in saline contrast studies where the intensity of the contrast cloud is typically greatest during hypoxic exercise; this could suggest that saline contrast studies could be confounded by different transit times. On the other hand, dogs (42) and rats (3) show no or very little microsphere passage at rest suggesting no Q IPAVA at rest, similar to saline contrast studies, though perhaps too few particulates were injected, making the detection of Q IPAVA very difficult particularly if shunt fractions were small. Indeed, the shunt fraction detected by 99m Tc-MAA in humans was calculated to be 0.4 Ϯ 0.1% (31) .
Contrast Stability Can Be Improved by Using Microbubbles Composed of Gases with High Density and Low Blood Solubility
Air and nitrogenous gases are often used as a contrast medium in agitated saline; however, with the invention of encapsulated and stabilized microbubbles that clear the pulmonary capillaries, these gases are less frequently used because of their high solubility and poor stability in blood (38) . Perfluorocarbons (e.g., SF 6 ) are preferred for their low solubility and high density, which, as theorized by Eq. 1, improve their stability in blood. We wondered if our quantitative approach to measure Q IPAVA could detect the improved stability of agitated saline contrast when SF 6 is utilized. As described above, the enhanced reflection of ultrasound waves with the SF 6 -fluid interface improves the sensitivity of detection by steepening the relationship between the injected dose and the measured contrast mass (see Fig. 3 ). In addition, we found that contrast bubbles composed of SF 6 were significantly stabilized such that across a normal pulmonary transit time of ϳ9 s, contrast conservation exceeded 100% (see Table 1 and Fig. 4 ). Considering that the acoustic intensity measurement does not count individual bubbles, an increase in the acoustic intensity signal and subsequently the contrast mass suggests that bubble growth may have occurred across the initial time course of the study. In fact, the growth of contrast bubbles composed of pure SF 6 would be predicted theoretically and experimentally (7, 23, 24) . After the initial injection into the system, dissolved gas will diffuse into the bubble down its concentration gradient causing the bubble to swell. Afterward, the bubble will begin to shrink as a result of the slow diffusion of gas into the fluid and may finally condense into a liquid if the external pressure becomes sufficiently large (23, 24) . While increasing the stability of agitated saline bubbles may improve the utility of the agitated saline technique for measuring Q IPAVA , it is unclear whether or not it could be safely used in human volunteers. Presumably, the stabilization of SF 6 bubbles would also lead to a significant increase in the risk of arterial gas embolism. Stabilized encapsulated microbubbles filled with SF 6 and designed to pass through the capillary vasculature are approved for use in humans, but control over bubble diameter is likely a key factor in their minimal risk profile (41) . With agitated saline contrast, there is no control over the size of the contrast bubbles, and its utility for the measurement of Q IPAVA requires that bubbles must be sufficiently large and stable.
Limitations
Our in vitro experimental apparatus requires several modifications for future studies to improve its utility for characterizing agitated saline contrast under physiological conditions. Several limitations of our study need to be acknowledged. First, to achieve the transit times used in this study, fluid pressure ranged from 170 to 380 mmHg. This level is 22-30 times greater than normal resting mean pulmonary artery pressure and 9 -11 times greater than that expected during exercise (43) or hypoxia (19) . The high pressure in our experimental apparatus would be expected to shorten the time to microbubble dissolution (48) and suggests that the effect of transit time on contrast dissolution is overestimated by our data. Interestingly, in the study by Vuille et al. (48) the decay of agitated saline contrast at pressures of 150 and 200 mmHg in a static system is much less than the decay observed in our study (Fig. 4) suggesting an important destabilizing effect of flow. Second, the shortest transit time achievable using our experimental apparatus was 9.12 Ϯ 0.03 s. This transit time is comparable with a normal resting pulmonary transit time. However, we were not able to provide the contrast conservation between detection sites at the much quicker transpulmonary transit times that would be expected during exercise and acute hypoxia. Nonetheless, it can be inferred from our data that the loss of agitated saline contrast mixed with air is rapidly lost within the first 9 s while bubbles composed of SF 6 are significantly stabilized across this time frame. Third, in this preliminary study, saline was selected as the fluid medium rather than blood. Since blood is more viscous than saline, the diffusivity term in Eq. 1 will be reduced thereby increasing the time to microbubble dissolution. Finally, the in vitro system lacks ventricles, some contrast may be lost in the right ventricle, and contrast bubbles may recirculate in the left ventricle, possibly overestimating bubble mass. In future studies, we recommend that the fluid medium be replaced with blood and the blood gases be suitably controlled. In doing so, it could be possible to identify the effect different blood gases have on the stability of agitated saline contrast.
Conclusion
Agitated saline contrast mass can be objectively quantified using either the AUC or the mass parameter from an indicator dilution model such as the LDRW model. Contrast bubbles composed of air are highly unstable such that the amount of contrast conserved between detection sites is dependent on the transit time. This has major implications for the measurement of Q IPAVA using agitated saline contrast echocardiography because the transpulmonary transit time is not normally constant across study conditions such as during exercise or with acute hypoxia. As a result, the magnitude of Q IPAVA should be corrected for changes in transit time. Finally, the high-density, low-solubility gas SF 6 sufficiently stabilizes contrast bubbles and might improve measurements of Q IPAVA , but its safety for use in humans needs evaluation and may prevent serial injections, a notable strength of the saline contrast method.
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